TNF and cancer: Persistent activation of NF-κB further induces the secretion of immunosuppressive cytokines (e.g., IL-6, TGF-β), shaping an immunosuppressive TME, enhancing cancer cell survival, and reducing the infiltration of T and NK cells expressing TNF superfamily ligands.21